Rhythm Pharmaceuticals (RYTM) Change in Intangibles (2023 - 2024)

Rhythm Pharmaceuticals (RYTM) reported Change in Intangibles of $500000.0 for Q3 2024, up 83.82% year-over-year from $272000.0 in Q4 2023, and down 98.75% quarter-over-quarter from $40.0 million in Q1 2024.

Rhythm Pharmaceuticals (RYTM) Change in Intangibles (2023 - 2024) Analysis & Trends

Rhythm Pharmaceuticals (RYTM) has 2 years of Change in Intangibles data on file, last reported at $500000.0 in Q3 2024.

  • Change in Intangibles for Q3 2024 came in at $500000.0, up 83.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $500000.0 (down 98.77% YoY), and the FY2025 annual result was $40.0 million, down 1.23% from the prior year.
  • Change in Intangibles slipped to $500000.0 in Q3 2024 per RYTM's latest filing, from $40.0 million in the prior quarter.
  • Over five years, Change in Intangibles peaked at $40.0 million in Q1 2024 and troughed at $272000.0 in Q3 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Rhythm Pharmaceuticals 6.59 Bn 6.25 Bn 52.96 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 500,000.00
Sep 30, 2024 500,000.00
Mar 31, 2024 40.00 Mn
Mar 31, 2024 40.00 Mn
Sep 30, 2023 272,000.00
Sep 30, 2023 272,000.00
Jun 30, 2023 875,000.00
Jun 30, 2023 875,000.00
Mar 31, 2023 4.52 Mn
Mar 31, 2023 4.52 Mn